Wall Street News, AI generated

latest news in Securities fraud

Regulatory Setbacks Spark Investor Lawsuits Against Trip.com and ImmunityBio

Regulatory Setbacks Spark Investor Lawsuits Against Trip.com and ImmunityBio

New Orleans, Wednesday, 6 May 2026.
Following severe regulatory actions—including an antitrust probe and an FDA warning—investors are launching lawsuits against major companies like Trip.com and ImmunityBio after their stocks plummeted over 19 percent.

SES AI Faces Investor Lawsuit After Revenue Claims Trigger Massive Stock Plunge

SES AI Faces Investor Lawsuit After Revenue Claims Trigger Massive Stock Plunge

Woburn, Wednesday, 6 May 2026.
Battery developer SES AI faces a major lawsuit after allegedly fabricating revenue and missing targets, triggering a staggering 37 percent stock plunge that exposed severe market risks.

ImmunityBio Faces Investor Lawsuits Following a $2 Billion Drop in Market Value

ImmunityBio Faces Investor Lawsuits Following a $2 Billion Drop in Market Value

San Diego, Wednesday, 29 April 2026.
ImmunityBio faces mounting lawsuits after alleged misleading claims about its cancer drug triggered an FDA warning, erasing $2 billion in market value and severely impacting shareholders.